Cory Nelson, MD
Sports Medicine · Scottsdale, AZNPI 1790945228
Payments from drug & device makers
What this record shows
18 manufacturers reported payments, led by Impactortho, Inc. at 48.7% of the total. Reporting peaked in 2021 at $1,345 and has fallen 74.3% since, to $346 in 2025.
Across 45 payments — averaging $56.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Impactortho, Inc.$1K
- Arthrex$591
- Aroa Biosurgery Incorporated$154
- Anika Therapeutics, Inc.$145
- Smith+Nephew$68
- Amgen$54
- plus $302 from 12 others
Across 4 payments — averaging $15,000 each. An ownership or investment interest held by the physician or an immediate family member.
- Lazurite Inc.$60K
What the payments were for
- Food & beverage$1,36053%
- Education$1,20047%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Impactortho, Inc. | 3 | $1,246 |
| Arthrex | 13 | $591 |
| Aroa Biosurgery Incorporated | 1 | $154 |
| Anika Therapeutics, Inc. | 1 | $145 |
| Smith+Nephew | 2 | $68 |
| Amgen(2 entities) | 4 | $54 |
| Orthofix Medical, Inc. | 7 | $54 |
| Johnson & Johnson(2 entities) | 2 | $46 |
| Vericel Corporation | 2 | $30 |
| Medartis Inc. | 1 | $29 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Bioventus LLC | 1 | $25 |
| Acell, Inc. | 1 | $20 |
| Si-bone, Inc. | 1 | $20 |
| AbbVie | 1 | $17 |
| Arteriocyte Medical Systems, Inc. | 1 | $15 |
| Dynasplint Systems Inc. | 1 | $11 |
| Electronic Waveform Lab, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,560 in reported general payments places this provider in the 55th percentile of 152 sports medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 144 | $1,407 |
| Methylprednisolone | 24 | $146 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Scottsdale
- Amon FerryScottsdale$482K
- John TokishScottsdale$387K
- Jordan LilesScottsdale$51K
- James ShahaScottsdale$31K
- Anikar ChhabraScottsdale$21K
- Douglas FreedbergScottsdale$17K
- Brent RichScottsdale$12K
- Matthew GulbrandsenScottsdale$9K
- Karan PatelScottsdale$8K
- Angelo MattalinoScottsdale$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.